Node Not Found: -velcade-Node Not Found: - darzalex-Node Not Found: - revlimid-Node Not Found: - xifaxan-Node Not Found: -blenoxane-Node Not Found: - lipodox-Node Not Found: - etopophos-Node Not Found: - revlimid-Node Not Found: - rituxan-Node Not Found: - marqibo-Node Not Found: -velcade-Node Not Found: - fragmin-Node Not Found: - lipodox-Node Not Found: - savaysa-Node Not Found: - lixiana-Node Not Found: - etopophos-Node Not Found: - xarelto-Node Not Found: - nolvadex-Node Not Found: - soltamox-Node Not Found: - venclexta-Node Not Found: - velban- Meetings - The ASCO Post
Advertisement

Advertisement

2019 Debates and Didactics in Hematology and Oncology

velcade
darzalex
revlimid
xifaxan

Tailoring Upfront Daratumumab Treatment for Some Patients With Multiple Myeloma

The monoclonal antibody daratumumab has been widely embraced for the treatment of multiple myeloma, but for newly diagnosed patients, its benefit has been proved only in some patients, according to Cr...

blenoxane
lipodox
etopophos
revlimid
rituxan
marqibo

Current Controversies in Lymphoma: From the Role of Liquid Biopsy to Ways to Improve Upon Standard Chemotherapy

Two topics that hematologists are currently grappling with were addressed at the 2019 Debates and Didactics Conference in Sea Island, Georgia, sponsored by Emory University Winship Cancer Institute, ...

velcade
fragmin
lipodox
savaysa
lixiana
etopophos
xarelto
nolvadex
soltamox
venclexta
velban

Conundrums in Managing Cancer-Associated Thrombosis

Although there may be a clear role for prophylactic anticoagulation in hospitalized patients and those undergoing surgery, indication for prophylactic anticoagulation for patients with cancer seen in...

Skin Cancer

Stage IV Melanoma: What Current Role Should Surgery Play?

Advanced melanoma has become a different entity in the era of immunotherapy and targeted agents. Considering the potential for good outcomes from systemic therapy in advanced disease, has the role of ...

Multiple Myeloma

Is It Time to Intervene in Smoldering Myeloma?

Early intervention in smoldering multiple myeloma prevents progression to symptomatic disease and should be strongly considered for patients meeting new criteria for high risk, according to Sagar Loni...

Lung Cancer
Immunotherapy

Optimal First-Line Therapy for Stage IV Non–Small Cell Lung Cancer: Immunotherapy Alone or With Chemotherapy?

Recent studies in non–small cell lung cancer (NSCLC) have shown benefit for combining checkpoint inhibitors with chemotherapy. Should combinations, therefore, be the first choice for treating patients...

Advertisement

Advertisement



Advertisement